US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Global Airway Stent/Lung Stent Market 2021: By Type (Tracheal Stents, Laryngeal Stents), By Product Type (Self-Expandable Stents, Non-Expandable Stents, Balloon-Expandable Stents), By Material (Metal Lung Stents), By End User (Hospitals, Ambulatory Surgery Centres, Others)Global Airway Stent/Lung Stent Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by Trusted Business Insights. The global airway stent/lung stent testing market report has been segmented on the basis of type, product type, end user, and region.Request Covid - 19 Impact
Global Airway Stent/Lung Stent Market: OverviewLung or airway stents are produced using metal, nitinol, stainless steel, silicon, hybrid, and other materials. Stents are tube-shaped devices, and some include tracheobronchial stent, which is inserted or placed into an airway for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
Global Airway Stent/Lung Stent Market: DynamicsIncreasing adoption of therapeutic treatments such as bronchoscopy, endoscopic therapy, and chemotherapies owing to rising geriatric population, prevalence of lung cancer and other respiratory diseases and disorders are among some of the key factors expected to drive growth of the global airway stent/lung stent market. Some major factors that could hamper market growth include poor reimbursement policies in certain countries. Lack of healthcare professionals to operate the procedure, and lack of proper healthcare infrastructure and required resources in developing countries.
Global Airway Stent/Lung Stent Market: Segment AnalysisAmong the type segments, the tracheal stents segment is expected to contribute major share in the global airway stent/lung stent market, owing to high adoption of bronchial stents and tracheal in the treatment of COPD, resulting in increasing demand for tracheal stents, which in turn is expected to drive revenue growth of this segment in the target market over the forecast period. Out of the available material types, the metal lung stent segment dominates the global market in terms of revenue contribution currently. Advantages of metal stents include thinner walls than other stents, ease of insertion, and lower risk of migration. These are among some of the major factors expected to drive revenue growth of this segment in the target market. Among the product type segments, the expandable stents segment is expected to account a higher revenue share as compared to other segments. Key factor driving growth of this segment is benefits offered such as easy insertion in bronchoscopy procedures and low risk of any complication and availability of expandable stents in small size.
Global Airway Stent/Lung Stent Market: Region AnalysisCurrently, the North America market accounts for major revenue share in the global market, and is projected to maintain its dominance over the forecast period. Presence of large number of hospitals, rising prevalence of diseases and disorders, growing geriatric population, and rising healthcare expenditure in the countries in the region are some of the factors driving growth of the market in North America. Furthermore, the market in Asia Pacific is expected to register highest growth rate over the forecast period. North America market is expected to be followed by Europe market, which is also projected to register significant revenue growth in global airway stent/lung stent market. This growth can be attributable to increasing number of new product launches with added innovation, increasing healthcare expenditure by government and increasing number of individuals having chronic diseases, coupled with rising need for treatment using stents. NOVATECH®, GSS™, DUMON ®, TRACHEOBRONXANE®, Optimos™, Uventa™, Niti-S™, SPAXUS™, NAGI™, BUMPY™, Polyflex™, Dynamic™, Alair™, CRE™, Ultraflex™ are the brands covered in this Airway Stent/Lung Stent report.
Below are the active patents related to Airway Stent/Lung Stent Market.Patent Number: US20160338822A1 Artifical implantable bronchus Abstract Implantable artificial bronchi for the treatment of chronic obstructive pulmonary diseases, such as pulmonary emphysema. The implantable artificial bronchus can be made with silicone or nitinol. The embodiments of this invention may be further associated with a one-way valve. Type: Grant Filed: 2016-05-17 Date of Patent: 2016-11-24 Assignee : Pulmair Medical Inc
Below are the leading companies profiled in this Airway Stent/Lung Stent Market Report:
Chapter 1 Methodology and Scope